Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Cormorant Asset Management
AddedFeb 13, 2024
UpdatedJun 28, 2026
Cormorant Asset Management

Cormorant Asset Management

Operating

Cormorant Asset Management: A Boston-based hedge fund sponsor specializing in biotech and life sciences.

Location
Boston, MA, US
Founded
2013
Firm
Compare
Portfolio
Employees

Cormorant Asset Management is an employee-owned hedge fund sponsor that provides its services to pooled investment vehicles.

The firm also focuses on both public and private market innovative companies in the biotechnology and life sciences marketplace. Cormorant Asset Management was founded in 2013 and is based in Boston, Massachusetts, United States.

Cormorant Asset Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments114
Current Portfolio Count78
Total Portfolio Exits3

Top Investment Stages

Series B35 (32.1%)
Series C29 (26.6%)
Series A25 (22.9%)
Series D14 (12.8%)
Post Ipo Equity6 (5.5%)

Stage Mix

Series B 32%Series C 27%Series A 23%Series D 13%Post Ipo Equity 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Synnovation Therapeutics logo

Synnovation Therapeutics

Supira Medical logo

Supira Medical

Vyne Therapeutics logo

Vyne Therapeutics

Triveni Bio logo

Triveni Bio

Akura Medical logo

Akura Medical

Star Therapeutics logo

Star Therapeutics

Fore Biotherapeutics logo

Fore Biotherapeutics

Rapport Therapeutics logo

Rapport Therapeutics

Adarx Pharmaceuticals logo

Adarx Pharmaceuticals

Nexo Therapeutics logo

Nexo Therapeutics

Myra Vision logo

Myra Vision

OnKure Therapeutics logo

OnKure Therapeutics

Bioventrix logo

Bioventrix

Andera Partners logo

Andera Partners

Chroma Medicine logo

Chroma Medicine

Tioga Cardiovascular logo

Tioga Cardiovascular

Garuda Therapeutics logo

Garuda Therapeutics

Ensoma logo

Ensoma

Fog Pharmaceuticals logo

Fog Pharmaceuticals

Orionis Biosciences logo

Orionis Biosciences

Atia Vision logo

Atia Vision

Moma Therapeutics logo

Moma Therapeutics

Adona Medical logo

Adona Medical

Electra Therapeutics logo

Electra Therapeutics

Arkuda Therapeutics logo

Arkuda Therapeutics

Cormorant Asset Management - Similar Investment Firms

Cormorant Capital logo

Cormorant Capital

Caxton Advantage Life Sciences Fund logo

Caxton Advantage Life Sciences Fund

Soros Capital Management logo

Soros Capital Management

Origin Capital Management logo

Origin Capital Management

Perseus-Soros Biopharmaceutical Fund logo

Perseus-Soros Biopharmaceutical Fund

Fairmount Funds Management logo

Fairmount Funds Management

fairmountfunds.com

Exome Asset Management logo

Exome Asset Management

exomeasset.com

Boston Common Asset Management logo

Boston Common Asset Management

Commonwealth Asset Management logo

Commonwealth Asset Management

cwamgroup.com

Corrum Capital Management logo

Corrum Capital Management

corrumcapital.com

Affinity Asset Advisors logo

Affinity Asset Advisors

Soros Fund Management logo

Soros Fund Management

sorosfundmgmt.com

Crescendo Asset Management logo

Crescendo Asset Management

Hambrecht & Quist Capital Management logo

Hambrecht & Quist Capital Management

Mirae Asset Capital Life Science logo

Mirae Asset Capital Life Science

Cormorant Asset Management - Classification

Also Known As
  • Cormorant Asset Management, LP
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 2 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6000Depository Institutions